GLP-1 medications may even help improve some of these comorbidities as weight decreases
Improved Health Metrics: Along with weight loss, many patients see improvements in blood sugar levels and other health markers
Clinical trials show average A1C reductions of 1.52.0%, with the greatest effect in people already taking insulin or sulfonylureas
However, it's important to note that the long-term effects of IF are still not fully understood, and there's some debate about whether IF is superior to continuous caloric restriction, as typically used with semaglutide medication, regarding health and weight loss benefits [4, 7]
The dose escalation requirement Most protocols start at 0.25mg weekly for four weeks, not because this dose produces optimal weight loss, but because it allows your body to adapt to the medication with minimal side effects